.svg){kind=avatar}
The Green Molecules® market is often discussed in terms of end products. But beneath those end markets is a more important question: how are these molecules actually made?
The answer is becoming increasingly diverse. The same molecule can be produced through fundamentally different mechanisms — biological catalysis by living systems, conventional chemical catalysis, or energy-driven conversion using heat, plasma, electrons, or pressure. Each carries different cost structures, scaling dynamics, infrastructure requirements, and trade-offs, and most real-world systems combine elements of more than one. Hydrogen can come from electrolysis, steam methane reforming with carbon capture, methane pyrolysis, or subsurface microbial processes. Methane can come from anaerobic digestion, landfill gas upgrading, or synthetic methanation. Fuels and chemicals can be produced through fermentation, catalysis, plasma-assisted conversion, or thermochemical processing.
For investors, utilities, and industrial operators, this distinction matters. The market is not simply choosing between molecules. It is choosing between production pathways. And each pathway carries different implications for deployment speed, capital intensity, reliability, carbon intensity, and infrastructure compatibility.
Equally important is what surrounds these production pathways: separation, purification, and pressure-management technologies that do not create new molecules but determine whether those molecules can reach market. We touch on these enabling layers here and will explore them further in a follow-on piece.
In this issue of the Green Molecules® Journal (Part 1), we focus on the three primary families of production pathways — biological, catalytic, and energy-driven — and how they are converging around similar end products. In Part 2, we will go deeper into the trade-offs, economics, and system-level considerations that ultimately determine which pathways scale.
A molecule does not carry a label that tells you how it was made. A kilogram of hydrogen, a molecule of methane, a gallon of sustainable fuel, or a chemical intermediate can look functionally identical at the point of use even if the production pathways are entirely different. That is one of the reasons Green Molecules® are so compelling: they can often plug into existing infrastructure and end markets while changing the way the molecule is produced upstream.
Methane is a good example. It can be extracted as natural gas, generated biologically through anaerobic digestion, produced synthetically by combining hydrogen and carbon dioxide, or upgraded from biogas streams through separation and processing. The end product may be pipeline-quality methane, but the economics and carbon profile depend heavily on the pathway.
Hydrogen follows the same pattern. It can be produced through electrolysis, steam methane reforming with carbon capture, methane pyrolysis, geologic or subsurface biological processes, or other emerging methods. Again, the end product is hydrogen. But the questions that matter are different: What is the input? How much energy is required? What infrastructure is needed? Is there a byproduct? What does the lifecycle carbon intensity look like? How quickly can the system be deployed?
This is why a Green Molecules® strategy cannot be built around molecule names alone. It must be built around pathway economics.
In practice, these categories are not strictly discrete. All molecular conversion is, at its core, chemistry — the breaking and forming of bonds. What differentiates the pathways is the dominant mechanism that drives that chemistry: a living organism, an engineered catalyst in a conventional reactor, or an energy input such as heat, plasma, or electrons. In many real systems these overlap directly. Thermocatalytic processes, for example, are simultaneously catalytic and energy-driven — a catalyst sets the reaction pathway while heat provides the activation energy. Plasma-catalytic systems combine non-thermal plasma with a catalyst surface. Electrocatalysis pairs an electron flux with catalytic active sites. The boundary between catalysis and energy-driven activation is more spectrum than wall.
The taxonomy below is therefore organized by the dominant activation mechanism rather than by rigid scientific category. The market is increasingly evaluating integrated systems that combine elements of biology, catalysis, and energy-driven activation rather than choosing between them.
Biological pathways are one of the most interesting routes for Green Molecules® because they rely on organisms, enzymes, and microbial systems to convert feedstocks into useful products. In simple terms, biology is chemistry done by living systems.
The most familiar example is anaerobic digestion, where organic waste is broken down by microbes to produce biogas, which can then be upgraded into renewable natural gas. This is not a new concept, but the technology around it is evolving quickly. Better monitoring, better process control, improved microbial performance, and bolt-on systems are making existing digesters more productive and more investable. In this context, biology is not just about building new facilities. It can also be about improving the performance of installed assets.
This is where companies like Vertus Energy are relevant. Vertus is focused on improving biomethane production by attaching technology directly to existing anaerobic digesters. The broader point is important: biological systems can be powerful because they often work within existing feedstock and infrastructure networks. Rather than requiring entirely new supply chains, they can enhance assets already producing biogas, RNG, or waste-derived fuels.
Biology also extends beyond RNG. Companies like Cemvita are using engineered microorganisms to convert carbon-containing feedstocks into fuels, chemicals, and other products. In this model, microbes become a kind of biological manufacturing platform. Instead of relying only on high heat, high pressure, or traditional petrochemical routes, biology can use microbial pathways to turn waste carbon, industrial byproducts, or other feedstocks into valuable molecules.
The appeal is clear. Biological processes can operate under milder conditions than many traditional industrial processes. They can use distributed feedstocks. They can sometimes be integrated into existing industrial or agricultural systems. And they offer the possibility of producing molecules that are difficult or expensive to make through conventional methods.
But biology also has trade-offs. Biological systems can be sensitive. They require careful control of temperature, pH, nutrients, impurities, and residence time. Feedstock variability can affect performance. Reaction kinetics are often slower than equivalent thermal or catalytic routes, which translates into larger reactor volumes and longer residence times to achieve commercial throughput. And scaling from lab to pilot to industrial production is genuinely difficult — biological systems do not always linearly scale, and the gap between bench-scale performance and industrial reactor economics has historically been one of the hardest hurdles in the space. A microbe that performs well in a controlled environment may behave differently when exposed to real-world feedstock streams, contamination risk, or continuous commercial operations.
That is the central biological trade-off: potentially lower-energy conversion and strong feedstock flexibility, but slower kinetics, higher sensitivity to operating conditions, and meaningful scale-up risk to industrial throughput.
For investors, the key diligence questions are practical. Can the system tolerate real feedstocks? Can it run continuously? What happens when the feedstock changes? How much downstream separation is required? Does the biology improve the economics of an existing system, or does it require a new system to be built around it?
Biology is powerful, but it is not magic. Its value lies in matching the right organism, feedstock, operating environment, and end market.
Catalysis is the historical foundation of the modern energy and chemical economy. Refineries, petrochemical plants, ammonia facilities, and methanol plants all rely on controlled chemical reactions, mediated by catalysts in engineered reactors, to rearrange molecules into more valuable forms. In Green Molecules®, this pathway remains central — but the inputs and carbon constraints are changing.
At a high level, catalytic pathways use catalysts, reactors, and process conditions to convert feedstocks into target molecules. Carbon dioxide and hydrogen can be combined to produce methanol, though this remains thermodynamically and economically demanding compared to fossil-derived methanol. Methane and steam can be reformed into syngas (the dominant industrial route), and dry reforming using methane and carbon dioxide is an emerging variant. Syngas can be upgraded into fuels and chemicals. Captured carbon can become a feedstock rather than a waste stream. The basic logic is familiar to industry: define the input, control the reaction, separate the product, and integrate into downstream markets.
This familiarity matters. Catalytic processes often benefit from decades of industrial experience around reactors, catalysts, separations, heat integration, and plant operations. That can make them easier for industrial partners to understand and underwrite compared to more novel approaches.
Catalysis also has a major advantage in product flexibility. A common intermediate like syngas can lead to multiple outputs, including methanol, hydrogen, synthetic fuels, and chemical precursors. This optionality can be valuable in volatile markets, where the best end product may vary by geography, policy, feedstock cost, or offtake demand.
Electrochemistry — driving reactions with electrons rather than thermal energy — sits within this broader pathway and is becoming increasingly important. Low-carbon electricity opens routes to molecules that traditional thermochemical processes can't reach economically, and modular electrochemical reactors can co-locate with renewable or stranded power.
Traditional catalysis and electrochemistry can be especially compelling when they produce drop-in outputs for existing markets: methanol, ethylene, SAF intermediates, hydrogen, or other chemical building blocks.
But catalysis has its own trade-offs. Many reactions require clean or consistent inputs. Catalysts can degrade. Reaction selectivity matters because producing the wrong mix of products increases separation costs. Some processes require significant heat, pressure, or electricity. And while catalysis may be industrially familiar, new reaction pathways still face scale-up risk.
The key economic issue is often not whether the reaction works. It is whether it works selectively, efficiently, continuously, and cheaply enough at scale.
That is the core catalytic trade-off: high product control and industrial familiarity, but potential sensitivity to energy input, catalyst performance, and downstream separation costs.
For investors and operators, the diligence questions are again practical. What is the conversion efficiency? What is the product slate? How much energy is required per unit of output? How pure must the feedstock be? How expensive is separation? Can the process run with intermittent power, or does it need steady-state operation? Can it fit into an existing facility, or does it require a purpose-built plant?
Catalytic and electrochemical pathways are likely to remain dominant in Green Molecules® because they map naturally onto existing industrial systems. But the winners will be those that solve not just the reaction, but the full process economics.
Energy-driven pathways are still chemistry — bonds break and reform — but the dominant driver is a physical energy input rather than a conventional thermal catalyst.
Plasma, electrons, or extreme pressure activate reactions that catalysis alone cannot reach economically, or unlock molecules from environments where conventional reactors cannot operate. In many cases, energy-driven pathways are tightly integrated with catalysis (plasma-catalytic, electrocatalytic, photocatalytic systems) rather than separate from it.
Plasma-driven chemistry is one of the most interesting examples in this category. Companies like enaDyne are using non-thermal plasma combined with catalysts to drive reactions that conventional thermal catalysis struggles to access economically.
The plasma generates highly reactive species at relatively low bulk temperatures, which opens new reaction pathways and lowers the energy threshold for activation. enaDyne is starting commercially with emission abatement at semiconductor fabs — a market with clear regulatory drivers, paying customers, and an established channel partner — with the longer-term goal of graduating into higher-value transformations such as dry methane reforming and other CO₂ and methane conversion processes.
The market relevance is significant: CO₂ and methane, two molecules often treated as emissions challenges, can eventually become inputs into chemical production. The goal is not just emissions reduction; it is value creation from underutilized carbon streams.
Methane pyrolysis is another energy-driven approach, where methane is thermally split into hydrogen and solid carbon (CH₄ → C + 2H₂). Unlike steam methane reforming, pyrolysis does not produce CO₂ as the direct carbon output; the carbon is separated as a solid co-product. The economics depend heavily on whether that carbon can find a value-added market — a non-trivial commercial challenge that has limited the pace of deployment in this segment to date.
Subsurface and reservoir-based processes also belong here, though they often combine energy-driven and biological mechanisms. Eclipse Energy is exploring subsurface hydrogen production using engineered microbiology in depleted reservoirs, leveraging existing geological pressure, temperature, and residual hydrocarbons as part of the production system. The broader idea is that legacy oil and gas assets may be repurposed to generate or unlock valuable molecules at scale, blurring the boundary between energy-driven and biological categories.
The advantage of energy-driven pathways is that they can be highly modular and equipment-driven, which may shorten deployment timelines compared to large new process plants. Many of them — plasma, electrolysis, electrocatalysis — are also electrified at their core, which positions them well in a system increasingly defined by low-carbon power.
But the trade-offs are real. Energy-driven systems can require significant power input, which directly affects unit economics and carbon intensity. Materials must tolerate heat, pressure, corrosion, or impurities. Equipment reliability matters. Mechanical and electrical systems must operate continuously in demanding environments. Scale-up from lab plasma reactors or pilot units to industrial throughput is non-trivial.
The energy-driven trade-off is therefore: strong electrification fit and equipment-based scalability, but high dependence on power input, materials performance, and mechanical reliability.
For investors, the questions are different from biology or pure conventional catalysis. What is the energy efficiency of the activation mechanism? What is the equipment lifetime? How much maintenance is required? What happens under variable operating conditions? Does the system create a new revenue stream, reduce operating cost, or both?
Energy-driven pathways can be highly compelling where they unlock chemistry that conventional thermal catalysis cannot reach economically — particularly when low-carbon electricity is available.
Taken together, these three pathways — biological, catalytic, and energy-driven — are less distinct buckets and more complementary ways of achieving the same outcome: converting inputs into valuable molecules at scale. As outlined across each section, the differences are not in what is ultimately produced, but in how energy is applied, how reactions are driven, and how systems are designed to operate in the real world .
In practice, the lines between these approaches are increasingly blurred. Biological systems rely on underlying chemistry. Catalytic systems are often enabled or enhanced by physical conditions such as heat, pressure, or electrons. Energy-driven approaches frequently integrate with catalysts or biological mechanisms to improve efficiency or unlock new reactions. The most compelling technologies are rarely purely one or the other — they are engineered combinations that optimize for feedstock, energy input, infrastructure, and end-market requirements.
That is what makes the market more complex — but also more investable. The question is no longer which pathway “wins,” but which pathway, or combination of pathways, fits best within a given system.
In this piece (Part 1), the goal has been to establish a clear framework for understanding how these pathways work and where they fit. In Part 2, we will build on this foundation by examining the trade-offs more directly — how these approaches compare on cost, scalability, infrastructure compatibility, and real-world deployment constraints, and what ultimately determines which technologies move from concept to commercial scale.